FMR LLC's passive stake update shows no material change in position or intent. Monitor next 13F filing for any shift in Fidelity's aggregate ARWR holdings.
ARWR drugs
ARWR drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 5 $57.46entry
- T+1 · 11d ago +1.22%α +0.91% · $58.16
- T+5 · 5d ago −17.94%α −21.23% · $47.15
- T+7 · todayOpen
- T+20 · in 17d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
FMR LLC (Fidelity) filed an amended Schedule 13G reporting beneficial ownership of 9,307,349 shares of Arrowhead Pharmaceuticals common stock as of September 30, 2026, representing 6.6% of shares outstanding. This is a routine passive stake update with no change in investment intent.
Key Financial Metrics
Key Facts
- FMR LLC reports 9,307,349 shares of ARWR common stock as of September 30, 2026
- Stake represents 6.6% of shares outstanding
- Filing is an amendment to Schedule 13G, confirming passive investment intent
- Filing made under Rule 13d-1(b), indicating ordinary course investment activity
Financial Impact
FMR LLC holds 9,307,349 shares valued at approximately $615 million based on $8.4B market cap and 6.6% stake
Risk Factors
- No material risks identified from this routine passive filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0000315066-26-002702 |
| Document: 0000315066-26-002702-index-headers.html | 0000315066-26-002702 |
| Document: 0000315066-26-002702-index.html | 0000315066-26-002702 |
| Document: 0000315066-26-002702.txt | 0000315066-26-002702 |
Track record
7 reports on ARWR
1 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +17.69% at T+5 after the Nov 2, 2026 report. 2 of 3 went positive at some point.
Filters
- Nov 12, 20264d ago 8-K Bearish 6/10 Entry $47.78 to $44.21 Now $44.21 +7.47% ▲ +7.47% +5.56% vs SPY
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Viewing Entry $57.46 to $58.16 Now $44.21 −23.06% ▲ +1.22% +0.91% vs SPY
- Nov 4, 202612d ago 8-K Bullish 5/10 Entry $61.65 to $57.46 Now $44.21 −28.29% ▼ −6.80% −2.39% vs SPY
- Nov 2, 202614d ago Institutional Cluster Bearish 4/10 Entry $59.53 to $61.65 Now $44.21 +25.73% ▼ −3.56% −1.91% vs SPY
- Sep 10, 20269w ago Institutional Cluster Mixed 5/10 Entry $82.76 to $82.85 Now $44.21 −46.58% ▲ +0.11% −0.74% vs SPY
- Aug 20, 202612w ago Insider Cluster Neutral 2/10 Entry $87.11 to $86.73 Now $44.21 −49.25% ▼ −0.44% −0.14% vs SPY
- Jun 16, 202621w ago 8-K Neutral 2/10 Entry $81.04 to $81.82 Now $44.21 −45.45% ▲ +0.96% +0.18% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers